cdw17-antigen and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

cdw17-antigen has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 1 studies

Other Studies

1 other study(ies) available for cdw17-antigen and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

ArticleYear
Quantitative analysis of LacCer/CDw17 in human myelogenous leukaemic cells.
    Cellular & molecular biology letters, 2003, Volume: 8, Issue:4

    LacCer/CDw17 is the most abundant GSL in neutrophils. The cell-surface and intracellular presence of LacCer was determined quantitatively using anti-CDw17 mAbs in a flow cytometry assay. The quantified alterations in the level of CDw17 antigen expression are consistent with alterations in LacCer content, determined chemically. Our results show that CDw17 antigen expression defines successive stages in the maturation of the myeloid cell. The assessment of cell-surface and intracellular CDw17 expression may be useful in evaluating neutrophil physiological status.

    Topics: Antigens, CD; Cell Membrane; Flow Cytometry; Humans; Lactosylceramides; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Neutrophils

2003